11 septiembre 2015
Genetic mutations called ‘escape variants’ in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according scientists. Their findings have implications for the continued development of therapeutics to treat Ebola virus disease, which has claimed the lives of over 11,000 people in West Africa since last year.
http://www.sciencedaily.com/releases/2015/09/150911140719.htm
